ArticleInvestigative ophthalmology & visual science2025
Helicobacter pylori Infection's Dual Impact on the Ocular Surface: Tear Secretion Disruption and Ocular Surface Microbiome Alteration.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Asymmetric Tear Secretion: Can This Disorder Help in Suspecting Gastroesophageal Reflux Disease and in Managing Sjögren's Disease? A Pilot Study.Medicina (Kaunas, Lithuania) · 2026Article
- Potential Influence of Helicobacter Pylori on Glaucoma-Related Alterations of Ocular Surface Microbiota and Dry Eye Disease Pathophysiology.Investigative ophthalmology & visual science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this study was to investigate the impact of Helicobacter pylori (H. pylori) infection on ocular surface homeostasis, including dry eye symptoms, ocular microbiota alterations, and related immune responses. Methods: Thirty-one H. pylori-positive (Hp_pos) and 30 H. pylori-negative (Hp_neg) subjects underwent dry eye assessments, including the Schirmer I test, noninvasive keratography first and average breakup times (NIKf-BUTs and NIKav-BUTs), tear meniscus height, meibomian gland loss, and the Ocular Surface Disease Index (OSDI). Sterile swabs were used to collect samples from each eye of subjects for 16S rRNA sequencing. Additionally, a murine H. pylori infection model was established to evaluate dry eye phenotypes and immune responses in the lacrimal gland. Results: Compared with Hp_neg subjects, Hp_pos subjects showed significantly reduced Schirmer I test results, NIKf-BUT, and NIKav-BUT, along with higher OSDI scores (all P < 0.05), whereas tear meniscus height and meibomian gland loss did not differ between the two groups. The ocular surface microbiota of Hp_pos subjects exhibited altered alpha and beta diversity, with 10 enriched genera (dominated by Veillonella and Capnocytophaga), which were characteristically associated with dry eye manifestations. In the murine model, infected mice at 6 weeks post-infection displayed aqueous tear deficiency, corneal epithelial barrier impairment, lacrimal gland infiltration of CD4+ and CD45+ T lymphocytes, and upregulated proinflammatory cytokines (IFN-γ, IL-17A, IL-4, TGF-β, TNFα, IL-6, and IL-1β). However, no significant differences were observed at 2 or 4 weeks post-infection. Conclusions: The H. pylori infection disrupts tear secretion and ocular surface microbiota, potentially via inducing T lymphocyte infiltration and lacrimal gland inflammation, contributing to dry eye pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.